Bio-Rad Laboratories Inc (BIO)
330.53
+2.17
(+0.66%)
USD |
NYSE |
Dec 24, 16:00
Bio-Rad Laboratories Cash from Investing (Quarterly): -55.64M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Agilent Technologies Inc | -954.00M |
| Bruker Corp | -67.60M |
| Azenta Inc | 195.33M |
| Harvard Bioscience Inc | -1.111M |
| Bionano Genomics Inc | -5.375M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 163.61M |
| Cash from Financing (Quarterly) | -95.99M |
| Free Cash Flow | 223.75M |
| Free Cash Flow Per Share (Quarterly) | 3.572 |
| Free Cash Flow to Equity (Quarterly) | 88.91M |
| Free Cash Flow to Firm (Quarterly) | 99.97M |
| Free Cash Flow Yield | 2.38% |